Detalhe da pesquisa
1.
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Br J Haematol
; 200(6): 731-739, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36541117
2.
TLR9 expression in chronic lymphocytic leukemia identifies a promigratory subpopulation and novel therapeutic target.
Blood
; 137(22): 3064-3078, 2021 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512408
3.
A national service for delivering CD19 CAR-Tin large B-cell lymphoma - The UK real-world experience.
Br J Haematol
; 198(3): 492-502, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35485402
4.
The architecture of neoplastic follicles in follicular lymphoma; analysis of the relationship between the tumor and follicular helper T cells.
Haematologica
; 105(6): 1593-1603, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31537685
5.
In vitro and in vivo evidence for uncoupling of B-cell receptor internalization and signaling in chronic lymphocytic leukemia.
Haematologica
; 103(3): 497-505, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242301
6.
Results of a multicentre UK-wide retrospective study evaluating the efficacy of brentuximab vedotin in relapsed, refractory classical Hodgkin lymphoma in the transplant naive setting.
Br J Haematol
; 179(3): 471-479, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28857136
7.
Outcomes of relapse in patients with deferred autologous stem cell transplant after achieving at least very good partial response following bortezomib, adriamycin, dexamethasone chemotherapy for newly diagnosed multiple myeloma in the phase II PADIMAC trial.
Br J Haematol
; 196(4): e33-e37, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636043
8.
Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial.
Br J Haematol
; 193(3): e19-e22, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33715154
9.
Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma?
Br J Haematol
; 191(1): 13-14, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557549
10.
Guidelines for the diagnosis and management of primary central nervous system diffuse large B-cell lymphoma.
Br J Haematol
; 184(3): 348-363, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30467845
11.
Obinutuzumab Versus Rituximab Immunochemotherapy in Previously Untreated iNHL: Final Results From the GALLIUM Study.
Hemasphere
; 7(7): e919, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37404773
12.
Upfront autologous haematopoietic stem-cell transplantation versus carfilzomib-cyclophosphamide-dexamethasone consolidation with carfilzomib maintenance in patients with newly diagnosed multiple myeloma in England and Wales (CARDAMON): a randomised, phase 2, non-inferiority trial.
Lancet Haematol
; 10(2): e93-e106, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36529145
13.
Progress and pitfalls with the use of image-guided personalised approaches in lymphoma.
Br J Radiol
; 94(1127): 20210609, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520671
14.
PET-guided treatment for personalised therapy of Hodgkin lymphoma and aggressive non-Hodgkin lymphoma.
Br J Radiol
; 94(1127): 20210576, 2021 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34520242
15.
Burkitt Lymphoma International Prognostic Index.
J Clin Oncol
; 39(10): 1129-1138, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502927
16.
Author Correction: High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.
Bone Marrow Transplant
; 55(4): 840, 2020 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862820
17.
Favourable outcomes for high-risk Burkitt lymphoma patients (IPI 3-5) treated with rituximab plus CODOX-M/IVAC: Results of a phase 2 UK NCRI trial.
EJHaem
; 1(1): 133-141, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35847742
18.
Extending potentially curative options for older patients with PCNSL.
Lancet Haematol
; 11(3): e171-e173, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301671
19.
Positron Emission Tomography Score Has Greater Prognostic Significance Than Pretreatment Risk Stratification in Early-Stage Hodgkin Lymphoma in the UK RAPID Study.
J Clin Oncol
; 37(20): 1732-1741, 2019 07 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31112475
20.
Results of a United Kingdom real-world study of polatuzumab vedotin, bendamustine, and rituximab for relapsed/refractory DLBCL.
Blood Adv
; 6(9): 2920-2926, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020818